EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 13-Dec-2025 11:11 ET (13-Dec-2025 16:11 GMT/UTC)

24-Jun-2025

City of Hope leads AI-powered health care innovations and launches generative AI tool to save lives and enable nationwide best-in-class cancer care

City of Hope is using generative artificial intelligence to create operational efficiency, enable AI-driven patient personalization, improve access to clinical trials and empower breakthrough research

24-Jun-2025

Scientists uncover cells’ survival strategy in low-nutrient environments

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

UCLA scientists have uncovered a surprising survival strategy in cancer cells that may help explain how MYC-driven cancers survive and grow despite limited resources.

Journal: Cancer & Metabolism
Funder: NIH/National Institutes of Health

24-Jun-2025

Dr. Tony Hunter awarded 2025 Szent-Györgyi Prize for pioneering cancer research

National Foundation for Cancer Research
Grant and Award Announcement

Tony Hunter, Ph.D., to be honored at the 2025 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship in Washington, D.C., for his landmark discovery that opened the field of tyrosine kinase signaling and revolutionized cancer treatment.

24-Jun-2025

“We’re aiming for a cure.” Massey and VIMM researchers achieve potential breakthrough in brain cancer treatment

Virginia Commonwealth University
Peer-Reviewed Publication

Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) discovered a new and potentially revolutionary way to treat glioblastoma (GBM), the most aggressive type of brain cancer with no curative treatment options. An innovative study – led by Paul B. Fisher, MPh, Ph.D., FNAI, and Swadesh K. Das, Ph.D., and recently published in the Journal for ImmunoTherapy of Cancer – created a novel molecule that demonstrated the capability to introduce a combination of treatment outcomes – direct toxicity and immunotoxicity – to kill the tumor while exploiting immunotherapy to potentially prevent the recurrence of GBM via a “Fusion Superkine” (FSK), containing dual acting therapeutic cytokines in a single molecule.

Journal: Journal for ImmunoTherapy of Cancer

24-Jun-2025

AI tool set to transform characterisation and treatment of cancers

Garvan Institute of Medical Research
Peer-Reviewed Publication

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within tumours, opening doors for more targeted therapies for patients.

Journal: Cancer Discovery

24-Jun-2025

Cancer treatments and Panama Canal efficiency: Purdue Innovates Incubator funds projects to advance university innovations

Purdue University
Grant and Award Announcement

Two Purdue University researchers have received $50,000 apiece to develop their innovations in the fields of cancer treatments and freshwater management. The funding comes from the Trask Innovation Fund, managed by Purdue Innovates Incubator. The fund supports Purdue researchers through the “valley of death," the time to move an innovation from laboratory creation to marketplace product.

Funder: Purdue Research Foundation

24-Jun-2025

WIN International Molecular Tumor Board recommends tailored treatment for advanced colorectal cancer

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – June 24, 2025 – A new precision oncology paper was published in Volume 16 of Oncotarget on June 17, 2025, titled “Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment.”

Journal: Oncotarget

24-Jun-2025

New protein targets for cancer treatments

Université de Genève
Peer-Reviewed Publication

Cells depend on the precise reading of DNA sequences to function correctly. This process, known as gene expression, determines which genetic instructions are activated. When this fails, the wrong parts of the genome can be activated, leading to cancers and neurodevelopmental disorders. Scientists at the University of Geneva (UNIGE) have identified two proteins that play a key role in regulating this essential mechanism, paving the way for promising new treatments that could be more effective and less toxic than those currently available. Their findings are published in Nature Communications.

Journal: Nature Communications

24-Jun-2025

Trusted oncology guidelines get a digital makeover: National Comprehensive Cancer Network launches NCCN Guidelines Navigator

National Comprehensive Cancer Network
Business Announcement

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—announces a new, interactive digital delivery format for the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).

24-Jun-2025

Gene mutation could be target for ‘ultrapersonalized’ therapies in colon cancer

Temple University Health System
Peer-Reviewed Publication

The recently published study offers new insights into KRAS, a gene that’s known to be involved in almost half of all cancers. It could be a step toward developing “ultrapersonalized” treatments for colon cancer, with therapies that precisely target not just the specific genes involved in a patient’s cancer but individual mutations of that gene.

Journal: Cell Reports